Cervical and anal neoplasia and HPV infection in persons with HIV infection.

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Prolonged, severe immunodeficiency provides the necessary milieu for the emergence of anogenital neoplasia caused by human papillomaviruses. Cervical and anal neoplasia are likely to become more common manifestations of HIV disease as patients with profound immunodeficiency, who would have succumbed to opportunistic infections earlier in the epidemic, are now surviving for extended periods of time because of increasingly effective antiretroviral, prophylactic, and antimicrobial therapies. Cervical cancer in the setting of HIV infection appears to be a more aggressive disease, less likely to be successfully treated by standard therapies, and consequently associated with a poorer prognosis than in comparable non-HIV-infected women. Anecdotal observations suggest that anal cancer in HIV-infected persons may share these features. Strategies need to be developed for earlier detection and treatment of neoplasia and anogenital cancer in the setting of HIV-induced immunodeficiency.

Original languageEnglish (US)
Pages (from-to)33-37
Number of pages5
JournalOncology (Williston Park, N.Y.)
Volume8
Issue number1
StatePublished - Jan 1994
Externally publishedYes

Fingerprint

HIV Infections
HIV
Infection
Neoplasms
Anus Neoplasms
Opportunistic Infections
Uterine Cervical Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Cervical and anal neoplasia and HPV infection in persons with HIV infection. / Northfelt, Donald W.

In: Oncology (Williston Park, N.Y.), Vol. 8, No. 1, 01.1994, p. 33-37.

Research output: Contribution to journalArticle

@article{cab6bf35489d49048c132ab5ba7e1a21,
title = "Cervical and anal neoplasia and HPV infection in persons with HIV infection.",
abstract = "Prolonged, severe immunodeficiency provides the necessary milieu for the emergence of anogenital neoplasia caused by human papillomaviruses. Cervical and anal neoplasia are likely to become more common manifestations of HIV disease as patients with profound immunodeficiency, who would have succumbed to opportunistic infections earlier in the epidemic, are now surviving for extended periods of time because of increasingly effective antiretroviral, prophylactic, and antimicrobial therapies. Cervical cancer in the setting of HIV infection appears to be a more aggressive disease, less likely to be successfully treated by standard therapies, and consequently associated with a poorer prognosis than in comparable non-HIV-infected women. Anecdotal observations suggest that anal cancer in HIV-infected persons may share these features. Strategies need to be developed for earlier detection and treatment of neoplasia and anogenital cancer in the setting of HIV-induced immunodeficiency.",
author = "Northfelt, {Donald W}",
year = "1994",
month = "1",
language = "English (US)",
volume = "8",
pages = "33--37",
journal = "Oncology",
issn = "0030-2414",
publisher = "UBM Medica Healthcare Publications",
number = "1",

}

TY - JOUR

T1 - Cervical and anal neoplasia and HPV infection in persons with HIV infection.

AU - Northfelt, Donald W

PY - 1994/1

Y1 - 1994/1

N2 - Prolonged, severe immunodeficiency provides the necessary milieu for the emergence of anogenital neoplasia caused by human papillomaviruses. Cervical and anal neoplasia are likely to become more common manifestations of HIV disease as patients with profound immunodeficiency, who would have succumbed to opportunistic infections earlier in the epidemic, are now surviving for extended periods of time because of increasingly effective antiretroviral, prophylactic, and antimicrobial therapies. Cervical cancer in the setting of HIV infection appears to be a more aggressive disease, less likely to be successfully treated by standard therapies, and consequently associated with a poorer prognosis than in comparable non-HIV-infected women. Anecdotal observations suggest that anal cancer in HIV-infected persons may share these features. Strategies need to be developed for earlier detection and treatment of neoplasia and anogenital cancer in the setting of HIV-induced immunodeficiency.

AB - Prolonged, severe immunodeficiency provides the necessary milieu for the emergence of anogenital neoplasia caused by human papillomaviruses. Cervical and anal neoplasia are likely to become more common manifestations of HIV disease as patients with profound immunodeficiency, who would have succumbed to opportunistic infections earlier in the epidemic, are now surviving for extended periods of time because of increasingly effective antiretroviral, prophylactic, and antimicrobial therapies. Cervical cancer in the setting of HIV infection appears to be a more aggressive disease, less likely to be successfully treated by standard therapies, and consequently associated with a poorer prognosis than in comparable non-HIV-infected women. Anecdotal observations suggest that anal cancer in HIV-infected persons may share these features. Strategies need to be developed for earlier detection and treatment of neoplasia and anogenital cancer in the setting of HIV-induced immunodeficiency.

UR - http://www.scopus.com/inward/record.url?scp=0028076622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028076622&partnerID=8YFLogxK

M3 - Article

C2 - 8123446

AN - SCOPUS:0028076622

VL - 8

SP - 33

EP - 37

JO - Oncology

JF - Oncology

SN - 0030-2414

IS - 1

ER -